Optiscan Imaging Limited (ASX:OIL) has completed the first prototype to collect images from the gastrointestinal (GI) tract ...

Medtech company Optiscan Imaging has rolled out a flexible endomicroscope prototype capable of capturing real-time images ...

The study will assess Optiscan’s Gen2 real-time imaging capability to diagnose and treat GI diseases, including cancer Optiscan Imaging Limited (ASX:OIL) has completed the first prototype to ...

Gastrointestinal involvement is common among patients with EGPA, with eosinophilic tissue infiltration, weight loss, and myalgia identified as significant predictors.

Optiscan said the collected images would be used to assess real-time imaging capability of its Gen2 technology in diagnosing and treating GI diseases, including cancer, and progress planning for ...

Optiscan Imaging Ltd (ASX:OIL) has commenced a pre-clinical study at a German university to assess the company’s Gen2 ...

The chronic diseases such as cancer, cardiovascular diseases is a factor driving the growth of the Global Diagnostic Imaging Agent Market. US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- ...